...
首页> 外文期刊>Scientific reports. >Replacement of the L-iduronic acid unit of the anticoagulant pentasaccharide idraparinux by a 6-deoxy-L-talopyranose – Synthesis and conformational analysis
【24h】

Replacement of the L-iduronic acid unit of the anticoagulant pentasaccharide idraparinux by a 6-deoxy-L-talopyranose – Synthesis and conformational analysis

机译:用6-脱氧-L-塔拉吡喃糖代替抗凝血五糖伊德拉帕林的L-艾杜糖醛酸单元-合成和构象分析

获取原文
           

摘要

One critical part of the synthesis of heparinoid anticoagulants is the creation of the L-iduronic acid building block featured with unique conformational plasticity which is crucial for the anticoagulant activity. Herein, we studied whether a much more easily synthesizable sugar, the 6-deoxy-L-talose, built in a heparinoid oligosaccharide, could show a similar conformational plasticity, thereby can be a potential substituent of the L-idose. Three pentasaccharides related to the synthetic anticoagulant pentasaccharide idraparinux were prepared, in which the L-iduronate was replaced by a 6-deoxy-L-talopyranoside unit. The talo -configured building block was formed by C4 epimerisation of the commercially available L-rhamnose with high efficacy at both the monosaccharide and the disaccharide level. The detailed conformational analysis of these new derivatives, differing only in their methylation pattern, was performed and the conformationally relevant NMR parameters, such as proton-proton coupling constants and interproton distances were compared to the corresponding ones measured in idraparinux. The lack of anticoagulant activity of these novel heparin analogues could be explained by the biologically not favorable 1C4 chair conformation of their 6-deoxy-L-talopyranoside residues.
机译:肝素类抗凝剂合成的一个关键部分是创建具有独特构象可塑性的L-艾杜糖酸结构单元,这对抗凝活性至关重要。本文中,我们研究了在类肝素寡糖中构建的更容易合成的糖(6-脱氧-L-塔洛糖)是否可以显示出类似的构象可塑性,从而可以成为L-异糖的潜在取代基。制备了与合成的抗凝血五糖伊德拉帕林有关的五种五糖,其中L-艾杜糖醛被6-脱氧-L-塔拉吡喃糖苷单元代替。通过在单糖和二糖水平上都具有高效功效的可商购的L-鼠李糖的C4差向异构体形成了配置了talo的结构单元。对这些新衍生物进行了详细的构象分析,只是它们的甲基化方式不同,并将构象相关的NMR参数(如质子-质子偶合常数和质子间距离)与在idraparinux中测得的相应参数进行了比较。这些新型肝素类似物缺乏抗凝活性的原因可能是它们的6-脱氧-L-塔洛吡喃糖苷残基的生物学上不利的 1 C 4 椅子构象。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号